Yes, hepatitis B infection commonly causes elevated liver enzymes, particularly during active phases of the disease.
Hepatitis B virus (HBV) infection is a well-established cause of elevated liver enzymes, with the pattern and degree of elevation varying by disease phase and viral activity. 1
Mechanism and Pattern of Enzyme Elevation
According to the most recent EASL 2025 guidelines, alanine aminotransferase (ALT) elevation is a defining feature of active hepatitis B phases 1:
- Phase 2 (HBeAg-positive chronic hepatitis B): Characterized by elevated ALT with moderate to high HBV DNA levels (10⁴-10⁷ IU/ml)
- Phase 4 (HBeAg-negative chronic hepatitis B): Shows persistently or intermittently elevated ALT with HBV DNA typically >2,000 IU/ml
In contrast, chronic HBV infection phases (Phase 1 and 3) typically present with normal ALT levels despite detectable virus, representing lower disease activity 1.
Clinical Evidence
Research demonstrates that approximately 80% of HBsAg-positive patients have abnormal ALT levels, while 20% maintain normal ALT despite active infection 2. This creates an important clinical pitfall: normal liver enzymes do not exclude hepatitis B infection or even significant liver disease.
The WHO 2024 systematic review found a dose-response relationship between HBV DNA levels and liver complications, with persistently elevated ALT associated with increased incidence of cirrhosis and liver-related mortality 3. This evidence led to expanded treatment criteria lowering the HBV DNA threshold from >20,000 IU/ml to >2,000 IU/ml.
Degree of Elevation
AST and ALT elevations in hepatitis B can range from mild to markedly elevated, depending on disease activity 2, 4:
- Blood levels rise even before clinical symptoms like jaundice appear
- In HBeAg-positive carriers, slight rises in liver enzymes correlate with high infectivity 5
- Patients with both hypertension and chronic HBV show the most pronounced elevations (ALT OR = 12.00, AST OR = 41.94) 4
Important Caveats
HBeAg-negative patients can have high viral replication with below-normal or normal ALT levels despite significant histologic changes 6. This represents a critical diagnostic challenge where monitoring ALT alone is insufficient.
Additionally, disproportionately high AST compared to ALT may indicate macro-AST (an immunoglobulin-AST complex) rather than true hepatocellular damage, which can be confirmed through PEG precipitation testing 7.
Clinical Approach
When evaluating elevated liver enzymes:
- Always test for HBsAg, anti-HBc, and HBV DNA to establish infection status 1
- Consider hepatitis B even with normal enzymes in high-risk populations
- Recognize that ALT elevation indicates hepatocellular damage but normal ALT doesn't exclude active disease 6
- Sequential measurements combined with virological markers enhance diagnostic accuracy 1